Moderna stock “took a life of its own” before the entry of the S&P 500
[ad_1] Moderna (MRNA) is expected to join the S&P 500 index on Wednesday, replacing Alexion Pharmaceuticals Inc. (ALXN). The stock has skyrocketed amid the pandemic after its vaccine became essential in the fight against the coronavirus. Moderna stock has “taken on a life of its own,” Jefferies managing director and senior research analyst Michael Yee … Read more